Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-performance proteomics reveals immune, epithelial, and vascular dysregulation underlying lacrimal fluid defects in patients with aniridia.

BMC ophthalmology·2026
Same author

Sexual Dimorphism Is Associated With Corneal Nerve and Epithelial Alterations and Tear-Film Defects in Pax6 Haploinsufficiency Mouse Model.

Investigative ophthalmology & visual science·2026
Same author

Hematocrit of granulocyte concentrates regulates neutrophils' function and viability.

Transfusion·2026
Same author

Injury-specific pathways shape corneal nerve regeneration dynamics.

Scientific reports·2025
Same author

Blood banks saving sight: collaboration for successful treatment of ligneous conjunctivitis.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2025
Same author

Production of viable and functional neutrophils in granulocyte concentrates with the Reveos automated system.

Vox sanguinis·2025

Related Experiment Video

Updated: Jun 16, 2026

Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

Hypersensitivity pneumonitis.

Mélissa Girard1, Yvon Cormier

  • 1Centre de recherche de l'Institut universitaire de Cardiologie et de Pneumologie de Québec, Quebec City, Quebec, Canada.

Current Opinion in Allergy and Clinical Immunology
|January 23, 2010
PubMed
Summary
This summary is machine-generated.

Recent reports reveal new causes and diagnostic insights for hypersensitivity pneumonitis (HP), a rare lung disease. Understanding HP

Related Experiment Videos

Last Updated: Jun 16, 2026

Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Environmental Health

Background:

  • Hypersensitivity pneumonitis (HP) is a complex hyperimmune pulmonary disease.
  • Numerous antigens and environmental exposures are known triggers.
  • Ongoing research identifies new sources and etiological factors.

Purpose of the Study:

  • To provide an updated review of recent clinical and basic science findings on hypersensitivity pneumonitis.
  • To highlight novel insights into the diagnosis, pathogenesis, and treatment of HP.
  • To inform clinicians and researchers about the evolving understanding of this rare lung condition.

Main Methods:

  • Comprehensive literature review of recent publications on hypersensitivity pneumonitis.
  • Analysis of clinical case reports and basic science studies.
  • Synthesis of new findings related to diagnosis, histopathology, outcomes, and immune mechanisms.

Main Results:

  • The literature continues to identify novel antigens and environmental settings causing HP.
  • New findings enhance the diagnostic approach, including histopathology.
  • Advances in understanding immune mechanisms offer potential for new therapeutic strategies.

Conclusions:

  • This review aids clinicians in diagnosing hypersensitivity pneumonitis and identifying diverse sources.
  • The presented findings will guide future research into HP pathophysiology.
  • The study aims to accelerate the development of novel treatments for this global orphan disease.